| Literature DB >> 25590925 |
Hugo Bizetto Zampa1, Dalmo A R Moreira1, Carlos Alberto Brandão Ferreira Filho1, Charles Rios Souza1, Camila Caldas Menezes1, Henrique Seichii Hirata1, Luciana Vidal Armaganijan1.
Abstract
BACKGROUND: The QRS-T angle correlates with prognosis in patients with heart failure and coronary artery disease, reflected by an increase in mortality proportional to an increase in the difference between the axes of the QRS complex and T wave in the frontal plane. The value of this correlation in patients with Chagas heart disease is currently unknown.Entities:
Mesh:
Year: 2014 PMID: 25590925 PMCID: PMC4290736 DOI: 10.5935/abc.20140162
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Clinical, electrocardiographic, echocardiographic and Holter findings of 72 patients with Chagas disease
| Characteristics | N (%) |
|---|---|
|
| |
| Age in years (mean ± standard deviation) | 59.3 ± 10.6 |
| Male gender | 35 (48.6) |
| Dyslipidemia | 27 (37.5) |
| Syncope | 43 (59.7) |
| Smoking | 5 (6.9) |
| Stroke or TIA | 7 (9.7) |
| Systemic arterial hypertension | 55 (76.4) |
| Diabetes mellitus | 10 (13.9) |
| Implantable cardioverter | 2 (2.8) |
| Pacemaker | 2 (2.8) |
|
| |
| I | 37 (51.4) |
| II | 30 (41.7) |
| III | 5 (6.9) |
| IV | 0 (0.0) |
|
| |
| Beta-blockers | 34 (47.2) |
| Amiodarone | 39 (54.2) |
| ACE inhibitors/ABRs | 57 (79.2) |
| Furosemide | 18 (25.0) |
| Statins | 21 (29.2) |
| Aspirin | 30 (41.7) |
| Oral anticoagulant | 2 (2.8) |
| Spironolactone | 19 (26.4) |
|
| |
| First degree ABV | 22 (30.6) |
| Right bundle branch block | 41 (56.9) |
| Left anterior superior hemiblock | 47 (65.3) |
| QRS < 120 ms | 24 (33.3) |
| QRS > 120 ms | 48 (66.7) |
| Normal QRS-T angle | 39 (54.2) |
| Abnormal QRS-T angle | 21 (29.2) |
| Borderline QRS-T angle | 10 (13.9) |
|
| |
| Ejection fraction (mean) | 49.8 ± 16.1% |
| Diastolic dysfunction | 42 (58.3) |
| Systolic dysfunction | 3 (4.2) |
| Intracardiac thrombus | 1 (1.4) |
| Left ventricular aneurysm | 3 (4.2) |
|
| |
| 0-10 ventricular extrasystoles / hour | 12 (16.7) |
| 11-30 ventricular extrasystoles / hour | 10 (13.9) |
| > 31 ventricular extrasystoles / hour | 43 (59.7) |
| Nonsustained ventricular tachycardia | 37 (51.4) |
TIA: transitory ischemic attack; ACE: angiotensin-converting enzyme; ABRs: angiotensin II receptor blockers; ABV: atrioventricular block.
Comparison of clinical characteristics between groups
| Clinical characteristics | Ventricular tachycardia / ventricular fibrillation induction | ||
|---|---|---|---|
| No 41 (56.4%) | Yes 31 (43.1%) | p value | |
| Age (years) | 61.98 | 55.77 | 0.01 |
| Male gender | 16 (39) | 19 (61.3) | 0.09 |
| Dyslipidemia | 16 (39) | 11 (35.5) | 0.81 |
| Syncope | 24 (58.5) | 19 (61.3) | 1.00 |
| Smoking | 3 (7.3) | 2 (6.5) | 1.00 |
| Previous stroke / TIA | 5 (12.2) | 2 (6.5) | 0.69 |
| Systemic arterial hypertension | 30 (73.2) | 25 (80.6) | 0.58 |
| Diabetes mellitus | 6 (14.6) | 4 (12.9) | 1.00 |
TIA: transitory ischemic attack.
Comparison between groups regarding use of concomitant medications
| Concomitant medications | Induction of ventricular tachycardia / ventricular fibrillation | ||
|---|---|---|---|
| No 41 (56.4%) | Yes 31 (43.1%) | P value | |
| Beta-blocker | 15 (36.6) | 19 (61.3) | 0.06 |
| Amiodarone | 22 (53.7) | 17 (54.8) | 1.00 |
| ACE inhibitors/ABRs | 33 (80.5) | 24 (77.4) | 0.78 |
| Furosemide | 10 (24.4) | 8 (25.8) | 1.00 |
| Statins | 16 (39.0) | 5 (16.1) | 0.04 |
| Aspirin | 22 (53.7) | 8 (25.8) | 0.03 |
| OA | 2(4.9) | 0 (0.0) | 0.50 |
| Spironolactone | 8 (19.5) | 11 (35.5) | 0.18 |
ACE: angiotensin-converting enzyme: ABRs: angiotensin II receptor blockers: OA: oral anticoagulant.
Comparison of electrocardiographic findings between groups
| Electrocardiographic findings | Induction of ventricular tachycardia / ventricular fibrillation | |||
|---|---|---|---|---|
| No 41 (56.4%) | Yes 31 (43.1%) | P value | ||
| First degree AVB | 12 (29.3) | 10 (32.3) | 0.80 | |
| Right bundle branch block | 25 (61.0) | 16 (51.6) | 0.48 | |
| Left anterior superior hemiblock | 29 (70.7) | 18 (58.1) | 0.32 | |
| QRS < 120 ms | 16 (39.0) | 8 (25.8) | ||
| QRS < 120 ms | 25 (61.0) | 23 (74.2) | 0.88 | |
|
| ||||
| Normal | 26 (63.4) | 13 (41.9) | 0.04 | |
| Borderline | 6 (14.6) | 4 (12.9) | ||
| Abnormal | 7 (17.1) | 14 (45.2) | ||
ABV: atrioventricular block.
Comparison of echocardiographic and Holter findings between groups
| Findings of echocardiogram and Holter | Induction of ventricular tachycardia / ventricular fibrillation | ||
|---|---|---|---|
| No 41 (56.4%) | Yes 31 (43.1%) | p value | |
| Left ventricular diastolic dysfunction | 26 (63.4) | 16 (51.6) | 0.47 |
| Right ventricular dysfunction | 1 (2.4) | 2 (6.5) | 0.57 |
| Left ventricular thrombus | 0(0.0) | 1 (3.2) | 0.42 |
| Mean ejection fraction | 55.12 | 42.57 | 0.03 |
| 0-10 ventricular extrasystoles / hour | 6 (14.6) | 6 (19.4) | 0.71 |
| 11-30 ventricular extrasystoles / hour | 5 (12.2) | 5 (16.1) | |
| > 31 ventricular extrasystoles / hour | 26 (63.4) | 17 (54.8) | |
Figure 1Left, electrocardiogram showing abnormal QRS-T angle (SÂQRS= -70º; SÂT = +100º; QRS-T 170º angle). Right, sustained monomorphic ventricular tachycardia induced during electrophysiological study of the same patient.
Multivariate analysis in patients who induced ventricular tachyarrhythmia during EPS
| Induction of ventricular tachycardia / ventricular fibrillation Ventricular | ||||
|---|---|---|---|---|
| OR | p value | CI | ||
| Age > 65 years | 0.25 | 0.04 | 0.06 - 0.97 | |
| Ejection fraction < 35% | 4.84 | 0.02 | 1.23 - 19.09 | |
| Beta-blocker use | 1.30 | 0.64 | 0.39 - 4.33 | |
| QRS < 120 ms | 1.35 | 0.65 | 0.37 - 4.90 | |
|
| ||||
| Normal | ||||
| Borderline | 1.23 | 0 80 | 0.24 - 6.14 | |
| Abnormal | 3.95 | 0.052 | 0.99 - 15.82 | |